Capital Calls: UK interventions, Post-virus reset 7 Sep 2021 Concise views on global finance: U.S. bidder TransDigm’s withdrawal from the $8.7 bln race for Meggitt removes a tricky decision for the government; Boris Johnson’s new proposals will address social care but not generational wealth divides.
Meggitt arm-wrestle is test for UK interventionism 3 Sep 2021 TransDigm’s 7 bln pound approach for the aerospace engineer is higher than rival Parker Hannifin’s but uses way more debt. PM Boris Johnson has been active in probing M&A that could affect jobs or national security. But intervening on leverage grounds would be a new departure.
Capital Calls: Pfizer M&A, Uber driver status 23 Aug 2021 The drugmaker has agreed to acquire Trillium Therapeutics for $2.3 billion, looking to its broader post-coronavirus strategy; a California judge has struck down a law exempting tech companies from treating drivers as full employees, complicating their push to keep costs down.
UK defence buyout tests government poker hand 16 Aug 2021 Private equity-backed Cobham is offering a 63% premium for rival Ultra Electronics. To get Britain’s approval for the 2.6 bln pound deal, it will make commitments on jobs and research. If those pledges are robust, owner Advent will have to work hard to earn a good return.
Shareholders exposed by British defence raid 23 Jul 2021 Some UK investors complain private equity buyers are stealing listed groups. A mooted 2.6 bln pound bid for Ultra Electronics by Advent-owned Cobham suggests otherwise. The buyer needs chunky cost savings to make it work. A 62% premium implies the market misjudged Ultra’s value.
Capital Calls: Sabers down for Project JEDI 10 May 2021 Concise views on global finance: The Pentagon may end the $10 billion cloud project to consolidate U.S. military data after exhausting worse options.
Capital Calls: Christine Lagarde, Bernie Madoff 14 Apr 2021 Concise views on global finance: The European Central Bank president’s quest for inflation will take a while to achieve its goal; investor gullibility will live on after the death of the Ponzi schemer in a U.S. federal prison.
Capital Calls: LVMH surges back to full health 13 Apr 2021 Concise views on global finance: The 300 billion euro luxury conglomerate’s first-quarter sales surpass pre-Covid-19 levels.
Babcock CEO’s reset comes with valuation upside 9 Apr 2021 David Lockwood may soon unveil a writedown at the 1 bln pound UK engineering group, which is also saddled with heavy debt. Those concerns obscure the relatively promising trend of UK defence spending. Lockwood’s CV offers hope of a cleanup – and significantly higher share price.
Capital Calls: Defence IPO, ViacomCBS and GameStop 24 Mar 2021 Concise views on global finance in the Covid-19 era: Italy’s Leonardo postpones the initial public offering of its U.S. unit; ViacomCBS and GameStop's rising stocks give them both a chance to raise fresh cash.
KKR finds lucrative new exit: German taxpayers 17 Dec 2020 The buyout firm is selling 25% of defence supplier Hensoldt to the government, which wants to block foreign buyers. Such trades usually incur a discount, but at $550 mln KKR is getting a rich premium. Dealing with increasingly activist states brings opportunity as well as risks.
BAE’s U.S. pivot can help defuse Saudi discount 20 Jan 2020 The $27 bln UK defence firm has bought satellite navigation and radio businesses from merger partners Raytheon and United Technologies. The $2.2 bln price looks fair. Greater sales in America, and a lesser reliance on Riyadh, should boost the Typhoon-maker’s depressed stock.
UK defence buyout is Exhibit A for cash glut 25 Jul 2019 Private-equity firm Advent and Blackstone funds are buying Cobham for 4 bln pounds, larding up to 2.5 bln pounds of leverage onto a company that has worked hard to have essentially none. It suggests both equity and debt investors have plenty of money and limited opportunities.
American M&A makes excess great again 28 Jun 2019 U.S. deals jumped 19% in the first half even as activity ebbed in Europe and Asia. Topping the list are pricey purchases by AbbVie, Bristol-Myers and Occidental, plus Raytheon’s questionable merger with United Technologies. Most buyers’ owners will regret their CEOs’ ambitions.
Viewsroom: When dealmaking gets difficult 13 Jun 2019 Raytheon and United Technologies’ planned $114 bln tie-up raises questions about strategy, cost cuts and executive overreach. It’s prompted their shares to tank and activist Bill Ackman to oppose it. And Fiat Chrysler and Renault’s mooted merger has crashed. Can they salvage it?
Saudi Arabia will feel Trump’s Iran slap too 22 Apr 2019 The U.S. president will fully enforce sanctions on Tehran’s oil exports. Riyadh must pump more to prevent crude prices spiking further, which it has the scope to do. But doing Trump’s bidding will rankle OPEC peers. And the administration has a track record of changing its mind.
UK army contractor’s next target lies overseas 3 Apr 2019 Submarine-fixer Babcock has hired Ruth Cairnie as its new chair. She inherits a moribund share price and a firm weighted to UK contracts that may wither if the opposition Labour party gains power. Further hiking overseas revenues is the first thing to push for.
Trump’s dubious defense and deficit budget is DOA 11 Mar 2019 The White House wish list for 2020 tots up to $4.7 trln, with a boost for the military and cuts for most everything else. It also counts on an unlikely 3 pct GDP growth rate to trim red ink over a decade. It’s a statement of position that gives Congress good grounds to ignore it.
Cooler Chinese military spending is cold comfort 6 Mar 2019 Beijing will dedicate just 5.9 pct of its budget to defence in 2019, after a splurge last year. Yet investments in unconventional weapons, plus a fishing fleet that pushes territorial claims with the help of a maritime militia, will keep the regional arms race simmering.
Bush paid history’s economic dividends forward 1 Dec 2018 During the 41st U.S. president's one term, Soviet communism fell and Iraq's invasion of Kuwait was foiled. The "kinder, gentler" Bush was the last of a Washington breed that sought compromise. He put country over party. His successors reaped, and then squandered, the benefits.